The structure of the insulin industry, for the treatment of diabetes and Novo strategy and competitive position in early 1982. The industry is undergoing significant change and Novo must decide how to protect and build its international position. Designed as an early event in the global strategy. A class can understand how Novo competed at international level in the past as it relates to the structure of the industry, and how changes in the industry will change accordingly to compete globally. Coalition factor unions in the list of strategic alternatives. "Hide
by Michael E. Porter, Michael Enright Source: Harvard Business School 20 pages. Publication Date: April 19, 1989. Prod. #: 389148-PDF-ENG
Related Case Solutions & Analyses:
Regulatory Uncertainty and Corporate Responses to Environmental Protection in China
SecondMarket – Providing Liquidity for Shareholders of Privately Held iContact
Systems Infrastructure at Google (B)
Bank of America-Merrill Lynch
Technology Legend in China
Private Communications Corp. (B)
A Big (Double) Deal: Anadarko’s Acquisition of Kerr-McGee and Western Gas Resources
STRATEGIES FOR DEVELOPING VALUE ADDED TAX IN SAUDI ARABIA
Keirsey Style Personality – Self Assessment
Metapath Case
